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Summary
Mitotic recombination (MR) between homologous chro-
mosomes is a mutational event that results in loss of
heterozygosity in half of the segregants at mitosis. Loss
of heterozygosity may have important biological con-
sequences. The purpose of this study was to describe
human variation in the spontaneous frequency of MR.
Using an immunoselection technique for isolating the
somatic mutations that result in loss of expression of
one of the codominant alleles at the HLA-A locus, we
have measured the frequency and molecular basis of so-
matic mutations in lymphocytes from a population of
young adults. Mutations were classified as being the re-
sult of intragenic changes, major deletions, or MR. Here
we show that the MR mutation frequency in females
was significantly greater than that in males but that in-
tragenic mutation frequency showed no associationwith
sex. Individual variation in MR frequency ranged over
more than two orders of magnitude and was not nor-
mally distributed. Furthermore, the observed number of
individuals from whom no mutants resulting from MR
were obtained was significantly greater than was ex-
pected. The endogenous level of MR may be under ge-
netic control. Given the association of loss of hetero-
zygosity with cancer initiation and progression, low
endogenous MR may confer a reduced lifetime risk of
cancer, and the converse may apply.
Introduction
Mitotic recombination (MR) is the result of reciprocal
exchange of genetic material between nonsister chro-
matids of homologous chromosomes in mitotic cells.
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MR is an important genetic event since, on average, half
of the daughter cells will have loss of heterozygosity
(LOH) distal to the recombination site after mitosis. Cu-
mulative LOH may be an important contributor to ag-
ing, to cancer initiation and progression, and to differ-
ential expression of the phenotype in genetic disease
(Qian and Germino 1997). In previous studies, we have
shown that MR is a relatively common mutational event
accounting for approximately one-third of spontaneous
mutations resulting in the loss of expression of one of
the codominant HLA-A alleles in peripheral-blood lym-
phocytes (Morley et al. 1990). The spontaneous fre-
quency of MR increases with age (Grist et al. 1992).
The frequency of MR increases in human cells in re-
sponse to a variety of DNA-damaging agents, which
indicates that MR may be an intended or unintended
by-product of DNA-repair mechanisms, as is well de-
scribed in lower eukaryotes. However, the normal var-
iation of spontaneous frequency of MR has not been
described in any higher eukaryote. Since it may be hy-
pothesized that high endogenous levels of MR will pre-
dispose certain individuals to cancer, we investigated the
frequency of MR in a large number of individuals within
a narrow age range.
Subjects and Methods
Study Population
Blood samples were obtained, through the Red Cross
Blood Bank (Adelaide, South Australia), from young
healthy donors and were typed by immunocytotoxicity
to identify individuals who were heterozygous for either
HLA-A2 or HLA-A3 or both. Only the age and sex of
each individual were additionally recorded. In the study
population of 105 individuals, 43 were male, with a
mean  SD age of years, and 62 were23.6  3.4
female, with a mean  SD age of years.23.7  3.2
The study was approved by the Committee on Clinical
Investigation of the Flinders Medical Centre (Ethics
Committee).
HLA-A Mutation Assay
The HLA-A mutation assay was performed as de-
scribed elsewhere (McCarron et al. 1989). In brief, lym-
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Table 1
Somatic MFs ( ) at the HLA-A Locus in Young Adults56#10
SOMATIC MFS (NO. OF
INFORMATIVE INDIVIDUALS) IN
STUDY POPULATIONa
Males Females Total
MUTATION
CATEGORY MF (N) MF (N) MF (N)
SEX
DIFFERENCEb
Allc 22.7 (43) 27.8 (62) 25.4 (105) NS
Intragenicc 22.5 (29) 18.1 (37) 19.9 (66) NS
MRd 3.3 (39) 8.2 (58) 5.8 (97) P = .022
Deletion NC (25) NC (33) NC (58)
a NC = not calculated (see text).
b NS = not significant.
c Geometric-mean mutation frequency.
d Median mutation frequency.
Figure 1 Spontaneous MF, measured at the HLA-A locus in
human lymphocytes, in young adults. Left panel, Spontaneous MF in
a population of 43 males and 62 females 18–30 years of age. The
geometric-mean MF is shown for each sex. Center panel, Spontaneous
MF resulting from intragenic point mutations or small deletionswithin
the HLA-A gene in 29 males and 37 females with informative poly-
morphisms. The geometric-mean MF is shown for each MF. Right
panel, Spontaneous MF resulting from MR events in 39 males and 58
females from the population. The median MF is shown for each.
phocytes isolated from peripheral blood were subjected
to immunoselection against either the HLA-A2 or HLA-
A3 epitope, by use of complement-fixing antibodies
BB7.2 (as anti–HLA-A2 antibody) (American Type Cul-
ture Collection) and XI23 (as anti–HLA-A3 antibody)
(a gift from Dr. Anne Martin of Centre Re´gional de
Transfusion Sanguine, Rennes, France) and rabbit com-
plement. Control lymphocytes were exposed to comple-
ment alone and to medium alone. Cells were then plated,
in 96-well microtiter plates, at cell densities of 2 cells/
well for control cells and cells/well for cells42 # 10
immunoselected with antibody and complement. The
culture medium contained conditioned medium (a
source of interleukin-2) and irradiated feeder cells
( cells/well). The cells were cultured at 37C in41 # 10
10% CO2, and plates were scored for clonal growth in
microwells 21 d. Cells from wells showing positive
growth were tested with antibody and complement to
confirm that they had lost the selected phenotype and
were mutant. The cloning efficiency for selected and non-
selected cells was calculated, by use of Poisson statistics,
from the number of negative wells in the microtiter
plates, and the spontaneous-mutation frequencywas cal-
culated from the ratio of cloning efficiency in the pres-
ence of selection to that in its absence. DNA was ob-
tained from each mutant clone, and the molecular nature
of the mutation was determined by study of polymorphic
loci on chromosome 6p. Mutations were classified as
being due to one of the following: (1) intragenic mu-
tation within the HLA-A gene, (2) a major deletion, or
(3) MR, according to retention of heterozygosity or
LOH at polymorphic loci located both within HLA-A
and distally. Mutant clones showing retention of het-
erozygosity both at a polymorphism in intron 3 of HLA-
A (Firgaira et al. 1994) and at a distal locus (either FXIII
or D6S89) have been shown to have intragenic point
mutations or small deletions (Male 1997). Retention of
heterozygosity distally but LOH at HLA-A was taken
to represent a major deletion of genetic material, and
distal LOH was taken to indicate a mutation arising
from MR. This approach to classification of mutations
has been validated elsewhere (Joseph et al. 1993).
Results
Some individuals were not informative at one or more
of the loci, and the number of informative individuals
for each class of mutation is indicated in the text. A total
of 1,929 clones were obtained from 105 individuals.
Mutation frequencies (MFs), both for the population as
a whole and by sex, are given in table 1, and the indi-
vidual data are presented in figure 1. Cells from seven
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Table 2
Observed and Expected Numbers of Individuals with 0 MR Mutants
TOTAL NO. OF INDIVIDUALS
NO. OF OBSERVED
INDIVIDUALS WITH
0 MR MUTANTS
MEAN
PROPORTION
OF MR
NO. OF EXPECTED
INDIVIDUALS WITH
0 MR MUTANTS
PROBABILITY OF
NO. OBSERVED
In all assays: 97 21 .20 15.9 .126
.25 12.1 .013
.30 9.6 .001
.35 7.8 66.6# 10
In assays with 10 clones: 67 8 .20 2.5 .004
.25 1.3 56.4# 10
.30 .67 75.6# 10
.35 .36 95.1# 10
individuals who were HLA-A2/A3 heterozygotes were
selected at both alleles. Only the geometric mean ofMFs
for these seven individuals was used in the calculation
of the mean MFs in the population. Geometric-mean
MFs are given for total MF and for intragenic MF, both
of which were normally distributed (Kolmogorov-Smir-
nov test). There was no significant difference between
the spontaneous total MF seen in males and that seen
in females ( , Wilcoxon rank-sum test).P = .1
The majority of mutant clones were due to intragenic
mutations. In 66 informative individuals, 815 of 1,135
clones were due to intragenic mutation. The mean pro-
portion of intragenic mutations per individual was
71.2%. The observed sex difference in the intragenicMF
was not significant.
Individual variation in MR was not normally distrib-
uted, and the median values of MR, both for the pop-
ulation as a whole and by sex, are given in table 1. There
was a significant sex difference in the frequency of mu-
tations resulting from MR, with females exhibiting a
higher MR frequency than was seen in males (P =
, Wilcoxon rank-sum test). The female:male sex ra-.022
tio of the median MF of MR was 2.5:1.
MR was observed in 528 (29.4%) of 1,795 clones
from 97 informative individuals, a finding that is in ex-
cellent agreement with our previously cited results from
a smaller sample (Morley et al. 1990). The mean pro-
portion of MR events per individual was 26.4%. Of the
97 informative individuals, there were 21 from whom
no MR mutant clones were recovered. Studies of some
individuals would be expected to have yielded no MR
clones by chance alone, given the number of clones re-
covered in each assay. Using Poisson statistics, we mod-
eled the number of individuals expected to show zero
MR mutant clones, both on the basis of the actual num-
ber of recovered clones and on the basis of various es-
timates of the expected proportion ofMRmutant clones.
The observed number of such individuals exceeded that
which was expected, regardless of whether or not anal-
ysis was restricted to assays in which 10 clones were
analyzed (table 2).
Fifty-eight individuals were informative for deletion
mutation. Of 1,015 clones, 27 (2.7%) were the result
of deletional events. This number precludes ameaningful
calculation of the mean or median MF for this class of
mutation. However, under the hypothesis that 2.7% of
spontaneous mutations were due to deletion, a statistical
analysis (Poisson statistic) showed that the number of
individuals displaying no deletion was in agreementwith
the number that was expected (data not shown).
Discussion
Spontaneous somatic MF has been studied at sev-
eral loci. At the hprt locus, we and others have found
that interindividual variation exists and that the MF
is in young adults (Morley et al. 1983)6∼ 3 # 10
and increases with age (Trainor et al. 1984). The ma-
jority of mutations resulting in the inactivation of the
hprt locus arise from point mutations or small dele-
tions within the hprt gene (Burkhart-Schultz et al.
1996). The hprt gene is located on the X chromosome
and consequently is hemizygous in males and func-
tionally hemizygous in females. It is likely that MR
does not occur on the X chromosome. The delay in
replication during S-phase between the X chromo-
somes in females may preclude MR, or segregation of
MR may be lethal because of dosage reasons. Ac-
cordingly, the study of mutations at X-linked loci does
not demonstrate the full spectrum of potential mu-
tational events.
There have been several studies of the frequency and
spectrum of mutations at autosomal loci. Mutations in-
volving glycophorin A and resulting in loss of the M or
N blood type have been measured, by flow cytometry,
in erythrocytes, and the results (Jensen et al. 1986; Aki-
yama et al. 1995) suggest levels of total mutations and
presumed MR mutations that are similar to those re-
ported here. However, the molecular basis of the mu-
tations cannot be determined in erythrocytes. Flow cy-
tometry has also been used to assess MF at the
T-cell–antigen receptor (Kyoizumi et al. 1990) and at the
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HLA-A gene (Kushiro et al. 1992). In both these reports,
the total MFs were observed to be up to an order of
magnitude higher than those reported here. However, in
the few mutant clones subsequently analyzed at the mo-
lecular level, the proportion of MR mutants was in ex-
cellent agreement with the mean population proportion
of MR reported here. MFs at the autosomal adenine
phosphoribosyl transferase (aprt) gene have been deter-
mined, in four obligatory heterozygotes for APRT de-
ficiency. The molecular basis of mutations in T-cell
clones was determined in two of these individuals in
whomMRwas responsible for themajority ofmutations
recovered (Gupta et al. 1997).
The present study has demonstrated an interindividual
variation in MR, exceeding two orders of magnitude.
Given the relatively young age of the unselected indi-
viduals in our study, we believe that it is unlikely that
the differences that we have observed in the frequencies
of MR are due to differing environmental exposures to
mutagens. The data suggest a bimodal distribution of
MR frequency, with ∼10% of individuals having an MR
frequency that is very low or zero and with 90% of
individuals having an approximately log-normal distri-
bution near a median of , with the median65.8# 10
proportion of mutations resulting from MR in an in-
dividual being 31%. At the upper extreme, MR becomes
the dominant type of somatic mutation in lymphocytes
from some individuals. For example, in one individual,
MR was responsible for 74% of 58 mutant clones an-
alyzed. To what extent these clones represent either truly
independent mutations in this individual or in vivo ex-
pansion of one or moremutated lymphocytes is presently
unknown, although we (McCarron et al. 1989) and oth-
ers (Gupta et al. 1997) have previously observed poten-
tial in vivo clonality only in a minority of cases. Indeed,
recent (unpublished) studies from our laboratory dem-
onstrate that, among unselected T cells in normal in-
dividuals, sibling T-cell clones are present at very low
levels (95% confidence interval [CI] 0%–3.1%). Even
so, the presence of sibling clones does not bias the best
estimate of MF in a population, although it increases
the variance (Morley 1996).
We have identified a group of individuals in whom
the endogenous absolute frequency of MR is truly very
low or zero. If MR does not occur in some individuals,
this may be due to the presence of a lethal recessive gene
that is distal to HLA-A and that is syntenic with the
nonselected allele. Such a putative locus would become
homozygous after recombination, resulting in death of
the cell and failure to recover mutants. It is also possible
that a form of F1 hybrid resistance that is mediated by
natural killer cells and that is known to function in the
mouse might select against homozygous HLA class
I–expressing cells in individuals with certain HLA hap-
lotypes. Alternatively, there may be genetic variation that
suppresses MR. We are unable to distinguish between
these possibilities in this study, although we do favor
genetic variation as an explanation for our observations.
Genetic control of MR is poorly described and merits
further study, since individuals who display a signifi-
cantly elevated MR frequency may be predisposed to
premature aging and cancer. Bloom syndrome is asso-
ciated with a high level of chromosomal instability and
a greatly increased risk of cancer (German 1997). An
elevated frequency of MR in Bloom syndrome has been
inferred from flow-cytometric studies (Langlois et al.
1989) and has been observed in T-cell clones (Kusunoki
et al. 1994). The gene mutated in Bloom syndrome (i.e.,
Blm) would appear to have a normal function suppress-
ing MR. Blm and genes with gene products known to
interact with Blm protein may be candidate genes for
polymorphisms giving rise to biological variation inMR
in the human population. More generally, failure or lack
of fidelity of other mechanisms, such as DNA-repair pro-
cesses, in maintaining the integrity of the genome may
contribute to the frequency of MR.
In this study, we have made the novel observation of
a sex difference in MR that shows a median female:male
ratio of 2.5:1. In humans, mieotic recombination also
occurs at a higher rate, per physical distance of DNA,
in females than in males. The genomewide female:male
meiotic recombination is 1.61:1. For chromosome 6, the
ratio is 1.96:1, and in the region between the centromere
and HLA-A, the ratio is reported to be 3.3:1 (Dib et al.
1996). These latter figures are based on 186 informative
meioses and, thus, on only ∼60 events in the region
between the centromere and HLA-A. We have assessed,
in 97 individuals, 528 MR events over the same genetic
interval, in deriving our estimate of median MR fre-
quency. The MR events that we have identified are over-
whelmingly independent events distributed across ∼1%
of the genome. It seems likely that this interval is suf-
ficiently large to be broadly representative of the genome
as a whole.
It is interesting that both meiotic recombination and
MR events are more common in females than in males.
Since MR presumably occurs in diploid germ cells that
undergo several hundred cell divisions by the end ofmale
fertility, it may be that accumulated LOH after MR is
a contributing factor to the reduction of fertility with
advancing age and that selection might weakly favor
males with a reduced frequency of MR. There is no
commonly accepted explanation for the observed sex
imbalance in meiotic recombination. However, if there
is conservation of genetic mechanisms controlling both
meiotic recombination and MR, then the benefit that
suppression of MR has in the production of male gam-
etes may explain the excess of female meiotic
recombination.
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